Get Quote

Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Game Rating: 2 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.